Similar articles

• Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.

  Sirotnak FM. Sirotnak FM. Biochim Biophys Acta. 1973 Mar 15;302(1):13-23. doi: 10.1016/0005-2744(73)90003-x. Biochim Biophys Acta. 1973. PMID: 4144236 No abstract available.
• Sequential blockade of the mycobacterial de novo folate pathway. A review.

  Morrison NE. Morrison NE. Int J Lepr Other Mycobact Dis. 1971 Jan-Mar;39(1):34-43. Int J Lepr Other Mycobact Dis. 1971. PMID: 4399473 Review. No abstract available.
• Potential antileprotic agents. 3. Inhibition of mycobacterial dihydrofolic reductase by 2,4-diamino-5-methyl-6-alkylquinazolines.

  DeGraw JI, Brown VH, Colwell WT. DeGraw JI, et al. J Med Chem. 1974 Jul;17(7):762-4. doi: 10.1021/jm00253a026. J Med Chem. 1974. PMID: 4209923 No abstract available.
• Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.

  Jackson RC, Niethammer D, Hart LI. Jackson RC, et al. Arch Biochem Biophys. 1977 Aug;182(2):646-56. doi: 10.1016/0003-9861(77)90545-8. Arch Biochem Biophys. 1977. PMID: 561567 No abstract available.
• Cancer research: from folate antagonism to molecular targets.

  Bertino JR. Bertino JR. Best Pract Res Clin Haematol. 2009 Dec;22(4):577-82. doi: 10.1016/j.beha.2009.09.004. Best Pract Res Clin Haematol. 2009. PMID: 19959110 Review.